X

Bruker Corp (BRKR) Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release

Newsdesk: